Medicine Pods (@medicinepods) 's Twitter Profile
Medicine Pods

@medicinepods

Internal Medicine, PRN

ID: 1790477906767978496

linkhttps://medicinepods.com/ calendar_today14-05-2024 20:23:01

197 Tweet

276 Followers

221 Following

Medicine Pods (@medicinepods) 's Twitter Profile Photo

🎙️ Your ultimate med podcast roundup! Tune in and level up your medical knowledge! 🌟 Beyond MD: medicinepods.com/beyond-md-with… 🌟 Rheum for the RC: medicinepods.com/rheum-for-the-… 🌟 JAMA Clinical Reviews JAMA: jamanetwork.com/journals/jama/… #MedTwitter #EBM #InternalMedicine

Medicine Pods (@medicinepods) 's Twitter Profile Photo

🫁 Chest X-rays made simple! In just 5 minutes, Dr. Michael Fralick walks you through a fast, foolproof approach to reading CXRs. 🎥 Watch here: youtube.com/watch?v=ZQ4dgw… #CXR #ChestXRay #MedTwitter #Radiology #InternalMedicine #MedEd

Medicine Pods (@medicinepods) 's Twitter Profile Photo

📬 Stay in the Loop with Medicine Pods! Sign up for our monthly newsletter at medicinepods.com to get the latest podcast episodes, medical infographics, and our featured qMonthly topics— delivered straight to your inbox! 📷The Intern At Work The Rounds Table

📬 Stay in the Loop with Medicine Pods! Sign up for our monthly newsletter at medicinepods.com to get the latest podcast episodes, medical infographics, and our featured qMonthly topics— delivered straight to your inbox! 📷<a href="/InternAtWork/">The Intern At Work</a>
<a href="/roundstable/">The Rounds Table</a>
Medicine Pods (@medicinepods) 's Twitter Profile Photo

🧂💊 New Nephro Trial Files: TBT edition ✅ Salt substitutes lower stroke risk without ↑ hyperK ✅ Indapamide reduces stroke & mortality in the elderly ✅ Intensive BP control (<120) in T2DM? No clear benefit 📩 Subscribe here: nephrotrialfiles.substack.com #Nephrology #MedTwitter

🧂💊 New Nephro Trial Files: TBT edition

✅ Salt substitutes lower stroke risk without ↑ hyperK
✅ Indapamide reduces stroke &amp; mortality in the elderly
✅ Intensive BP control (&lt;120) in T2DM? No clear benefit

📩 Subscribe here: nephrotrialfiles.substack.com

#Nephrology #MedTwitter
Medicine Pods (@medicinepods) 's Twitter Profile Photo

👶 Managing medical issues in pregnancy just got easier Michael Fralick's one-pager covers: ✅ Safe meds in pregnancy ✅ Expected lab changes ✅ Imaging dos and don’ts 📖 Grab the full book: amazon.ca/One-Pagers-War… #MedTwitter #Obstetrics #InternalMedicine #MedEd

👶 Managing medical issues in pregnancy just got easier

<a href="/FralickMike/">Michael Fralick</a>'s one-pager covers:
✅ Safe meds in pregnancy
✅ Expected lab changes
✅ Imaging dos and don’ts

📖 Grab the full book: amazon.ca/One-Pagers-War…

#MedTwitter #Obstetrics #InternalMedicine #MedEd
Medicine Pods (@medicinepods) 's Twitter Profile Photo

🎙️This week, Drs. Michael Fralick & John Fralick host the next episode from our Clinical Practice Guidelines series discussing the top takeaways from the 2024 KDIGO Clinical Practice Guidelines for chronic kidney disease! 📄Listen now at medicinepods.com ‼️

Medicine Pods (@medicinepods) 's Twitter Profile Photo

🎉 The The Intern At Work's Ask A Fellow series is back, and we’re kicking things off with none other than Heme/Onc Fellow Dr. Stefan Jevtic! 🩸 Don't forget to check out cbcmadeeasy.com to help you master labs with a hands-on approach! Listen now at medicinepods.com‼️

Medicine Pods (@medicinepods) 's Twitter Profile Photo

qMonthly: ADA 2025 edition! This month’s takeaways: ✅ MariTide (monthly GLP1-GIP) leads to 15% weight loss ✅ Orforglipron (oral GLP1) ↓ A1C by ~1.3% & weight by ~6% ✅ Stem cell–derived islets restore insulin independence in T1DM medicinepods.com/qmonthly #ADA2025 #MedTwitter

qMonthly: ADA 2025 edition!

This month’s takeaways:
✅ MariTide (monthly GLP1-GIP) leads to 15% weight loss
✅ Orforglipron (oral GLP1) ↓ A1C by ~1.3% &amp; weight by ~6%
✅ Stem cell–derived islets restore insulin independence in T1DM

medicinepods.com/qmonthly

#ADA2025 #MedTwitter
Medicine Pods (@medicinepods) 's Twitter Profile Photo

🎙️Welcome back Rounds Table Listeners! We are back with a special Rapid Fire Podcast. This week, Dr. Michael Fralick and guest host Danielle Cutler discuss the top papers from the 2025 American Diabetes Association (ADA) Scientific Session! Listen now on medicinepods.com📑

The Curbsiders (@thecurbsiders) 's Twitter Profile Photo

🎧 New #Curbsiders episode! 💊 #490: Anticoagulation for VTE w/ Dr. Tara Lech, PharmD Tara Lech PharmD, CACP ✅ Choosing the right DOAC 🤰 Special pops: pregnancy, low BMI ✈️ Air travel prophylaxis 🚨 Treatment failure & reversal agents 🔗 thecurbsiders.com

🎧 New #Curbsiders episode!

💊 #490: Anticoagulation for VTE w/ Dr. Tara Lech, PharmD
<a href="/AnticoagPharmD/">Tara Lech PharmD, CACP</a> 

✅ Choosing the right DOAC
🤰 Special pops: pregnancy, low BMI
✈️ Air travel prophylaxis
🚨 Treatment failure &amp; reversal agents

🔗 thecurbsiders.com
Medicine Pods (@medicinepods) 's Twitter Profile Photo

📜 Throwback Trials! 🫁 TAP-IT: Thoracentesis in AHF didn’t improve outcomes ❌ Reldesemtiv in ALS: No benefit, trial stopped early 💨 HFNC 60 vs 40 L/min: No ↓ reintubation, but ↓ escalation w/ 60 L/min 🔗 trialfiles.substack.com/p/thoracentesi… #Cardiology #ALS #CriticalCare

📜 Throwback Trials!

🫁 TAP-IT: Thoracentesis in AHF didn’t improve outcomes
❌ Reldesemtiv in ALS: No benefit, trial stopped early
💨 HFNC 60 vs 40 L/min: No ↓ reintubation, but ↓ escalation w/ 60 L/min

🔗 trialfiles.substack.com/p/thoracentesi…

#Cardiology #ALS #CriticalCare
Medicine Pods (@medicinepods) 's Twitter Profile Photo

🎙️NEW The Rounds Table EPISODE! This week Dr. John Fralick discusses a recently published trial exploring the effects of add-on sotatercept in patients with advanced pulmonary arterial hypertension and a high risk of death!🫁☠️ Listen now at medicinepods.com‼️

Medicine Pods (@medicinepods) 's Twitter Profile Photo

Check out this infographic from The Intern At Work at medicinepods.com‼️Building on last week’s discussion of hematologic conditions in pregnancy, this week’s infographic dives into pregnancy-related VTE🩸

NEJM (@nejm) 's Twitter Profile Photo

Among 550 patients with stroke due to large-vessel occlusion who had presented within 4.5 hours after onset, 90-day functional outcomes were better with intravenous tenecteplase before thrombectomy than with thrombectomy alone. Full BRIDGE-TNK trial results and Research Summary:

Among 550 patients with stroke due to large-vessel occlusion who had presented within 4.5 hours after onset, 90-day functional outcomes were better with intravenous tenecteplase before thrombectomy than with thrombectomy alone. Full BRIDGE-TNK trial results and Research Summary:
CORE IM (@coreimpodcast) 's Twitter Profile Photo

#TriviaTuesday Urine osmolality is a window into which hormone’s activity? Review hyponatremia diagnostics and use this graphic on the wards! coreimpodcast.com/2021/02/10/5-p…

#TriviaTuesday 

Urine osmolality is a window into which hormone’s activity? 

Review hyponatremia diagnostics and use this graphic on the wards! 

coreimpodcast.com/2021/02/10/5-p…
Medicine Pods (@medicinepods) 's Twitter Profile Photo

📜 Throwback Trials this week: 💊 TAVI: Aspirin alone = ↓ bleeding vs DAPT 🧪 BICAR-ICU: Bicarb didn’t reduce death/organ failure in severe acidemia 🦠 CAP-START: Beta-lactam alone noninferior for non-ICU CAP 🔗 trialfiles.substack.com/p/trial-files-… #MedEd #TAVI #Acidemia #Pneumonia #RCTs

📜 Throwback Trials this week:

💊 TAVI: Aspirin alone = ↓ bleeding vs DAPT
🧪 BICAR-ICU: Bicarb didn’t reduce death/organ failure in severe acidemia
🦠 CAP-START: Beta-lactam alone noninferior for non-ICU CAP

🔗 trialfiles.substack.com/p/trial-files-…

#MedEd #TAVI #Acidemia #Pneumonia #RCTs
Medicine Pods (@medicinepods) 's Twitter Profile Photo

🚨 Introducing Heme Onc Trial Files 🛡️ GVHD prophylaxis: Cyclophosphamide+cyclosporin = ↑ GvHD-free/relapse-free survival 🧬 CML: Asciminib > TKIs for 48-wk MMR, fewer AEs 🧪 Myeloma: Isatuximab + VRd = ↑ PFS & deeper responses 🔗 hemeonctrialfiles.substack.com #HemeOnc #GVHD #CML

🚨 Introducing Heme Onc Trial Files

🛡️ GVHD prophylaxis: Cyclophosphamide+cyclosporin = ↑ GvHD-free/relapse-free survival
🧬 CML: Asciminib &gt; TKIs for 48-wk MMR, fewer AEs
🧪 Myeloma: Isatuximab + VRd = ↑ PFS &amp; deeper responses

🔗 hemeonctrialfiles.substack.com

#HemeOnc #GVHD #CML
Medicine Pods (@medicinepods) 's Twitter Profile Photo

On this week's The Rounds Table episode, Dr. Michael Fralick sits down with Dr. Karim Ladak, rheumatologist, internist, & host of the Rheumatology for the Royal College podcast, to talk about leukocytoclastic vasculitis. Listen now at medicinepods.com🎙️